Atlas Trials

Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity

Clinical trial NCT04439045 · COMPLETED

Trial details

NCT number
NCT04439045
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2020-06-24
Primary completion
2021-09-09
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.